Literature DB >> 2843674

Identification of Marek's disease virus nuclear antigen in latently infected lymphoblastoid cells.

L T Wen1, A Tanaka, M Nonoyama.   

Abstract

A new Marek's disease virus (MDV) nuclear antigen (MDNA) was identified in two MDV-transformed T-lymphoblastoid cell lines, MKT-1 and MSB-1, derived from chickens bearing tumors induced by MDV. This MDNA was not detected in MSB-1 cells maintained in iododeoxyuridine, which activates the latent MDV genome. Moreover, it was not found in chicken embryo fibroblasts undergoing productive and cytolytic infection with MDV. Expression of MDNA is not related to strain pathogenicity in chickens, because chicken embryo fibroblasts productively infected with the pathogenic RBIB strain or the nonpathogenic CV-1 strain of MDV did not express this antigen. DNA-protein immunoprecipitation studies revealed that MDNA bound to two sites in the 190,00-base-pair (bp) MDV genome. One of these loci identified by MDNA obtained from MKT-1 and MSB-1 cells corresponded to a 476-bp segment within the short unique region of BamHI-A MDV DNA. A second locus located in a 280-bp segment within the short inverted repeat region of BamHI-A was also identified by MDNA from MSB-1 cells but not by MDNA obtained from MKT-1 cells. Analyses of the nucleotide sequence by DNase digestion showed that MDNA protected a 60-bp segment spanning a 22-bp palindromic sequence of the short unique region and a 103-bp sequence encompassing a 32-bp palindrome in the short inverted repeat region of BamHI-A MDV DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843674      PMCID: PMC253520          DOI: 10.1128/JVI.62.10.3764-3771.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

2.  Biochemical evidence of the nonintegrated status of Marek's disease virus DNA in virus-transformed lymphoblastoid cells of chicken.

Authors:  A Tanaka; S Silver; M Nonoyama
Journal:  Virology       Date:  1978-07-01       Impact factor: 3.616

3.  Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells.

Authors:  K Nakajima; K Ikuta; M Naito; S Ueda; S Kato; K Hirai
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

4.  Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.

Authors:  K Hennessy; F Wang; E W Bushman; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

Authors:  B H Rispens; H van Vloten; N Mastenbroek; H J Maas; K A Schat
Journal:  Avian Dis       Date:  1972-04       Impact factor: 1.577

6.  Latent DNA of Epstein-Barr virus: separation from high-molecular-weight cell DNA in a neutral glycerol gradient.

Authors:  A Tanaka; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Replicating molecules of polyoma virus DNA.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1969-02-28       Impact factor: 5.469

8.  Immunization against Marek's disease using a live attenuated virus.

Authors:  A E Churchill; L N Payne; R C Chubb
Journal:  Nature       Date:  1969-02-22       Impact factor: 49.962

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.

Authors:  S Lupton; A J Levine
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  2 in total

1.  Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus.

Authors:  J L Cantello; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

2.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.